Chapter 1: Executive summary 1.1. Market scope and segmentation 1.2. Key questions answered in this study 1.3. Executive summary Chapter 2: Cancer screening market – market overview 2.1. Global market overview – market trends, market attractiveness analysis, geography-wise market revenue (USD) 2.2. Global – market drivers and challenges 2.3. Value chain analysis – cancer screening market 2.4. Porter’s five forces analysis 2.5. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics) 2.3. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.3. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.3. c. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.6. Market segmentation based on screening type (laboratory, genetic, imaging, biopsy and endoscopy) 2.4. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.4. b. genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.4. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.4. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations. 2.4. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations. 2.7. Market segmentation based on application type (lung, breast, melanoma, kidney and colorectal) 2.7. a. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.7. b. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.7. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations 2.7. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations. 2.7. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations. Chapter 3: Competitive landscape 3.1. GE Healthcare 3.1. a. Company snapshot 3.1. b. Product offerings 3.1. c. Strategic initiatives 3.1. d. Geographical presence 3.1. e. Key numbers 3.2. Siemens Healthineers 3.2. a. Company snapshot 3.2. b. Product offerings 3.2. c. Strategic initiatives 3.2. d. Geographical presence 3.2. e. Key numbers 3.3. Abbott Diagnostics 3.3. a. Company snapshot 3.3. b. Product offerings 3.3. c. Strategic initiatives 3.3. d. Geographical presence 3.3. e. Key numbers 3.4. F. Hoffmann-La Roche AG 3.4. a. Company snapshot 3.4. b. Product offerings 3.4. c. Strategic initiatives 3.4. d. Geographical presence 3.4. e. Key numbers 3.5. Thermo Fisher Scientific 3.5. a. Company snapshot 3.5. b. Product offerings 3.5. c. Strategies initiatives 3.5. d. Geographical presence 3.5. e. Key numbers 3.6. Hologic Inc. 3.6. a. Company snapshot 3.6. b. Product offerings 3.6. c. Strategies initiatives 3.6. e. Geographical presence 3.6. f. Key numbers 3.7. Becton, Dickinson and Company 3.7. a. Company snapshot 3.7. b. Product offerings 3.7. C. Strategic initiatives 3.7. e. Geographical presence 3.7. f. Key numbers 3.8. Qiagen 3.8. a. Company snapshot 3.8. b. Product offerings 3.8. c. Strategic initiatives 3.8. e. Geographical presence 3.8. f. Key numbers 3.9. Philips 3.9. a. Company snapshot 3.9. b. Product offerings 3.9. c. Strategic initiatives 3.9. e. Geographical presence 3.9. f. Key numbers 3.10. Illumina 3.10. a. Company snapshot 3.10. b. Product offerings 3.10. c. Strategic initiatives 3.10. e. Geographical presence 3.10. f. Key numbers Chapter 4: Conclusion Chapter 5: Appendix 5.1. List of tables 5.2. Assumptions 5.3. Research and methodology 5.4. About Netscribes Inc.

1. GE Healthcare 2. Siemens Healthineers 3. Abbott Diagnostics 4. F. Hoffmann-La Roche AG 5. Thermo Fisher Scientific 6. Hologic Inc. 7. Becton, Dickinson and Company 8. Qiagen 9. Philips 10. Illumina